Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Transplantation

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 89 articles:
HTML format
Text format



Single Articles


    May 2019
  1. HALDAR D, Kern B, Hodson J, James Armstrong M, et al
    Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis: a European Liver Transplant Registry Study.
    J Hepatol. 2019 May 6. pii: S0168-8278(19)30272.
    PubMed     Text format     Abstract available


    April 2019
  2. HARMS MH, van Buuren HR, Corpechot C, Thorburn D, et al
    Ursodeoxycholic Acid Therapy and Liver Transplant-free Survival in Patients with Primary Biliary Cholangitis.
    J Hepatol. 2019 Apr 10. pii: S0168-8278(19)30228.
    PubMed     Text format     Abstract available


    March 2019
  3. JAIN V, Burford C, Alexander EC, Sutton H, et al
    Prognostic markers at adolescence in patients Biliary Atresia for liver transplantation in adulthood.
    J Hepatol. 2019 Mar 12. pii: S0168-8278(19)30143.
    PubMed     Text format     Abstract available


  4. WONG TC, Fung JY, Yu-Shi Cui T, Lam AH, et al
    Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
    J Hepatol. 2019 Mar 11. pii: S0168-8278(19)30139.
    PubMed     Text format     Abstract available


  5. FERLA F, Lauterio A, De Carlis R, Di Sandro S, et al
    Comment on the article "Age and liver transplantation".
    J Hepatol. 2019 Mar 2. pii: S0168-8278(19)30121.
    PubMed     Text format    


    February 2019
  6. SCHLEGEL A, Muiesan P
    Reply to: "The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation".
    J Hepatol. 2019 Feb 20. pii: S0168-8278(19)30076.
    PubMed     Text format    


  7. HESSHEIMER AJ, Coll E, Ruiz P, Gastaca M, et al
    The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation.
    J Hepatol. 2019 Feb 16. pii: S0168-8278(19)30014.
    PubMed     Text format    


  8. IM GY, Cameron AM, Lucey MR
    Liver transplantation for alcoholic hepatitis.
    J Hepatol. 2019;70:328-334.
    PubMed     Text format     Abstract available


    January 2019
  9. GRANCINI V, Trombetta M, Lunati ME, Boselli ML, et al
    Central role of the beta-cell in driving regression of diabetes after liver transplantation in cirrhotic patients.
    J Hepatol. 2019 Jan 21. pii: S0168-8278(19)30028.
    PubMed     Text format     Abstract available


  10. TAYLOR R, Allen E, Richards JA, Goh AM, et al
    Survival advantage for patients accepting the offer of a circulatory death liver transplant.
    J Hepatol. 2019 Jan 10. pii: S0168-8278(19)30010.
    PubMed     Text format     Abstract available


  11. GOLDARACENA N, Gorgen A, Doyle A, Hansen BE, et al
    Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation.
    J Hepatol. 2019 Jan 7. pii: S0168-8278(19)30003.
    PubMed     Text format     Abstract available


    December 2018
  12. HESSHEIMER AJ, Coll E, Torres F, Ruiz P, et al
    Normothermic regional perfusion versus super rapid recovery in controlled donation after circulatory death liver transplantation.
    J Hepatol. 2018 Dec 21. pii: S0168-8278(18)32632.
    PubMed     Text format     Abstract available


  13. DURAND F, Levitsky J, Cauchy F, Gilgenkrantz H, et al
    Age and Liver Transplantation.
    J Hepatol. 2018 Dec 18. pii: S0168-8278(18)32626.
    PubMed     Text format     Abstract available


  14. ICHAI P, Laurent-Bellue A, Camus C, Moreau D, et al
    Liver transplantation in patients with liver failure related to exertional heatstroke.
    J Hepatol. 2018 Dec 3. pii: S0168-8278(18)32575.
    PubMed     Text format     Abstract available


    November 2018
  15. DE MEIJER VE, Fujiyoshi M, Porte RJ
    Ex situ machine perfusion strategies in liver transplantation.
    J Hepatol. 2018 Nov 5. pii: S0168-8278(18)32436.
    PubMed     Text format    


  16. ROY A, Taneja S
    Type of organ failure and acute insult have important bearings in outcomes of liver transplantation: A pragmatic discourse.
    J Hepatol. 2018 Nov 3. pii: S0168-8278(18)32384.
    PubMed     Text format    


  17. THULUVATH PJ, Thuluvath AJ, Hanish S, Savva Y, et al
    Reply to: "Type of organ failure and acute insult have important bearings in outcomes of liver transplantation: A pragmatic discourse".
    J Hepatol. 2018 Nov 2. pii: S0168-8278(18)32496.
    PubMed     Text format    


    October 2018
  18. SCHLEGEL A, Muller X, Kalisvaart M, Muellhaupt B, et al
    Outcomes of liver transplantations from donation after circulatory death (DCD) treated by hypothermic oxygenated perfusion (HOPE) before implantation.
    J Hepatol. 2018 Oct 17. pii: S0168-8278(18)32457.
    PubMed     Text format     Abstract available


  19. O'BRIEN A, Kamath PS, Trotter J
    MACHT - Outpatient albumin infusions do not prevent complications of cirrhosis in patients on the liver transplant waiting list.
    J Hepatol. 2018 Oct 9. pii: S0168-8278(18)32444.
    PubMed     Text format    


  20. BERENGUER M, de la Rosa Rodriguez G, Dominguez-Gil B
    Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.
    J Hepatol. 2018;69:966-968.
    PubMed     Text format    


    September 2018
  21. FERNANDEZ J, Saliba F
    Liver transplantation in patients with ACLF and multiple organ failure: Time for priority after initial stabilization.
    J Hepatol. 2018 Sep 18. pii: S0168-8278(18)32372.
    PubMed     Text format    


    August 2018
  22. SOLA E, Sole C, Simon-Talero M, Martin-Llahi M, et al
    MIDODRINE &ALBUMIN for Preventing COMPLICATIONS IN PATIENTS WITH CIRRHOSIS AWAITING Liver transplantation.
    J Hepatol. 2018 Aug 20. pii: S0168-8278(18)32285.
    PubMed     Text format     Abstract available


  23. TERRAULT NA, Pageaux GP
    A changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over!
    J Hepatol. 2018 Aug 10. pii: S0168-8278(18)32276.
    PubMed     Text format    


  24. ASRANI SK, Saracino G, O'Leary JG, Gonzalez S, et al
    Corrigendum to "Recipient characteristics and morbidity and mortality after liver transplantation" [J hepatol 69 (2018) 43-50].
    J Hepatol. 2018 Aug 7. pii: S0168-8278(18)32268.
    PubMed     Text format    


  25. HERZER K, Gerken G, Kroy D, Tacke F, et al
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany.
    J Hepatol. 2018 Aug 6. pii: S0168-8278(18)32179.
    PubMed     Text format    


    July 2018
  26. THULUVATH PJ, Thuluvath AJ, Hanish S, Savva Y, et al
    Liver Transplantation in Patients with Multiple Organ Failures: Feasibility and Outcomes.
    J Hepatol. 2018 Jul 30. pii: S0168-8278(18)32259.
    PubMed     Text format     Abstract available


  27. LAUTERIO A, Moioli MC, Di Sandro S, Travi G, et al
    HIV-positive to HIV-positive liver transplantation: To be continued.
    J Hepatol. 2018 Jul 23. pii: S0168-8278(18)32180.
    PubMed     Text format    


  28. OLDANI G, Peloso A, Vijgen S, Wilson EM, et al
    Chimeric liver transplantation reveals interspecific graft remodelling.
    J Hepatol. 2018 Jul 19. pii: S0168-8278(18)32260.
    PubMed     Text format     Abstract available


    June 2018
  29. HUTCHINSON JA, Schlitt HJ
    Subclinical T cell-mediated liver transplant rejection: The jury is still out.
    J Hepatol. 2018 Jun 30. pii: S0168-8278(18)32157.
    PubMed     Text format    


  30. BELLI LS, Perricone G, Adam R, Cortesi PA, et al
    Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
    J Hepatol. 2018 Jun 22. pii: S0168-8278(18)32163.
    PubMed     Text format     Abstract available


  31. BRINKERT F, Pukite I, Krebs-Schmitt D, Briem-Richter A, et al
    Allogeneic hematopoietic stem cell transplantation eliminates alloreactive inhibitory antibodies after liver transplantation for bile salt export pump deficiency.
    J Hepatol. 2018 Jun 20. pii: S0168-8278(18)32156.
    PubMed     Text format     Abstract available


  32. AGARWAL K, Castells L, Mullhaupt B, Rosenberg WMC, et al
    Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients.
    J Hepatol. 2018 Jun 7. pii: S0168-8278(18)32124.
    PubMed     Text format     Abstract available


  33. THULUVATH PJ, Thuluvath AJ, Savva Y
    Karnofsky Performance Status Before and After Liver Transplantation Predicts Graft and Patient Survival.
    J Hepatol. 2018 Jun 5. pii: S0168-8278(18)32110.
    PubMed     Text format     Abstract available


    April 2018
  34. LONDONO MC, Souza LN, Lozano JJ, Miquel R, et al
    Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients.
    J Hepatol. 2018 Apr 27. pii: S0168-8278(18)32022.
    PubMed     Text format     Abstract available


  35. SCHLEGEL A, Kalisvaart M, Isaac J, Muiesan P, et al
    Reply to: DCD consensus and futility in Liver Transplantation.
    J Hepatol. 2018 Apr 13. pii: S0168-8278(18)31977.
    PubMed     Text format    


  36. GIORGAKIS E, Khorsandi SE, Jassem W, Heaton N, et al
    "DCD consensus and futility in Liver Transplantation".
    J Hepatol. 2018 Apr 12. pii: S0168-8278(18)31976.
    PubMed     Text format    


  37. LUCIDI C, Lattanzi B, Riggio O, Merli M, et al
    May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?
    J Hepatol. 2018 Apr 4. pii: S0168-8278(18)30213.
    PubMed     Text format    


  38. VAN VUGT JLA, Alferink LJM, Buettner S, Metselaar HJ, et al
    Reply to: "May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?" and "Has the time come for using MELD-Sarcopenia score?"
    J Hepatol. 2018 Apr 3. pii: S0168-8278(18)30212.
    PubMed     Text format    


    March 2018
  39. MATHUR AK, Talwalkar J
    Quality measurement and improvement in liver transplantation.
    J Hepatol. 2018 Mar 17. pii: S0168-8278(18)30173.
    PubMed     Text format     Abstract available


  40. SCHLEGEL A, Kalisvaart M, Isaac J, Dutkowski P, et al
    Reply to: Redefining futility in DCD liver transplantation in the era of novel perfusion technologies.
    J Hepatol. 2018 Mar 14. pii: S0168-8278(18)30153.
    PubMed     Text format    


  41. ONISCU GC, Watson CJE, Wigmore SJ
    Redefining futility in DCD liver transplantation in the era of novel perfusion technologies.
    J Hepatol. 2018 Mar 14. pii: S0168-8278(18)30152.
    PubMed     Text format    


  42. LUTHER J, Dienstag JL
    Reply: Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30141.
    PubMed     Text format    


  43. DELTENRE P, Marot A, Dubois M, Trepo E, et al
    Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30142.
    PubMed     Text format    


    February 2018
  44. CRESPO G, Trota N, Londono MC, Mauro E, et al
    The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in wait-list composition.
    J Hepatol. 2018 Feb 23. pii: S0168-8278(18)30129.
    PubMed     Text format     Abstract available


  45. ASRANI SK, Saracino G, O'Leary JG, Gonzales S, et al
    Recipient characteristics and morbidity and mortality after liver transplantation.
    J Hepatol. 2018 Feb 14. pii: S0168-8278(18)30120.
    PubMed     Text format     Abstract available


  46. YOON YI, Song GW, Lee SG, Hwang S, et al
    Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    J Hepatol. 2018 Feb 13. pii: S0168-8278(18)30113.
    PubMed     Text format     Abstract available


  47. KIM AY, Sinn DH, Jeong WK, Kim YK, et al
    Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
    J Hepatol. 2018 Feb 2. pii: S0168-8278(18)30071.
    PubMed     Text format     Abstract available


    December 2017
  48. VAN VUGT JLA, Alferink LJM, Buettner S, Gaspersz MP, et al
    A Model including Sarcopenia Surpasses the MELD Score in Predicting Waiting List Mortality in Cirrhotic Liver Transplant Candidates.
    J Hepatol. 2017 Dec 5. pii: S0168-8278(17)32474.
    PubMed     Text format     Abstract available


  49. O'GRADY JG
    Relaxing Access to Liver Transplantation with Living Donation: A Foolish Move or a Time to Change?
    J Hepatol. 2017 Dec 2. pii: S0168-8278(17)32477.
    PubMed     Text format    


    November 2017
  50. FAITOT F, Besch C, Battini S, Ruhland E, et al
    Impact of real-time metabolomics in liver transplantation: graft evaluation and donor-recipient matching.
    J Hepatol. 2017 Nov 27. pii: S0168-8278(17)32447.
    PubMed     Text format     Abstract available


  51. KUBILIUN M, Patel SJ, Hur C, Dienstag JL, et al
    Early liver transplantation for alcoholic hepatitis: Ready for primetime?
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32452.
    PubMed     Text format    


  52. SCHLEGEL A, Kalisvaart M, Scalera I, Laing RW, et al
    The UK-DCD-Risk-Score: a new proposal to define futility in Donation after Circulatory Death liver transplantation.
    J Hepatol. 2017 Nov 15. pii: S0168-8278(17)32432.
    PubMed     Text format     Abstract available


  53. LINECKER M, Krones T, Berg T, Niemann CU, et al
    Potentially Inappropriate Liver Transplantation in the Era of the "Sickest-first" Policy - A Search for the Upper Limits.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32430.
    PubMed     Text format     Abstract available


    October 2017
  54. CHOUDHARY NS, Saraf N, Soin AS
    Liver Transplantation for Grade 3 Acute on Chronic Liver Failure: Type of Organ Failure is Important.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32401.
    PubMed     Text format    


  55. ARTRU F, Louvet A
    Reply to <<Liver transplantation for grade 3 acute-on-chronic liver failure: type of organ failure is important>>.
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32402.
    PubMed     Text format    


  56. LIEBER SR, Schiano TD, Rhodes R
    Should Living Donor Liver Transplantation Be an Option When Deceased Donation Is Not?
    J Hepatol. 2017 Oct 31. pii: S0168-8278(17)32405.
    PubMed     Text format     Abstract available


  57. LONDONO MC, Forns X, Pascasio JM
    Reply to: "Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations".
    J Hepatol. 2017 Oct 25. pii: S0168-8278(17)32385.
    PubMed     Text format    


  58. AZAB M, Shah S, Liu X, Ukken J, et al
    Extended DAA indications for hepatitis C patients awaiting liver transplantation and further statistical considerations.
    J Hepatol. 2017 Oct 24. pii: S0168-8278(17)32390.
    PubMed     Text format    


  59. GUSTOT T, Agarwal B
    Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation.
    J Hepatol. 2017;67:667-668.
    PubMed     Text format    


    September 2017
  60. VERHOEVEN CJ, Selten JW, Roest HP, Farid WRR, et al
    Corrigendum to "MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation" [J Hepatol 2013; 59:1231-1238].
    J Hepatol. 2017 Sep 27. pii: S0168-8278(17)32279.
    PubMed     Text format    


  61. LIU X, Shen JJ, Jung Kim S, Lee YJ, et al
    Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation.
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32290.
    PubMed     Text format    


    August 2017
  62. SAMUEL D, Sanchez-Fueyo A
    Immunotherapy in liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32049.
    PubMed     Text format    


  63. PASCASIO JM, Vinaixa C, Ferrer MT, Colmenero J, et al
    Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
    J Hepatol. 2017 Aug 22. pii: S0168-8278(17)32215.
    PubMed     Text format     Abstract available


  64. RAJAKANNU M, Coilly A, Adam R, Samuel D, et al
    Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation.
    J Hepatol. 2017 Aug 21. pii: S0168-8278(17)32214.
    PubMed     Text format    


  65. DONATO MF, Invernizzi F, Rossi G, Iavarone M, et al
    Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence.
    J Hepatol. 2017 Aug 10. pii: S0168-8278(17)32200.
    PubMed     Text format    


  66. KARLSEN TH, Folseraas T, Thorburn D, Vesterhus M, et al
    Primary sclerosing cholangitis - a comprehensive review.
    J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32196.
    PubMed     Text format     Abstract available


    July 2017
  67. TRIVEDI PJ, Scalera I, Slaney E, Laing RW, et al
    Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    J Hepatol. 2017 Jul 6. pii: S0168-8278(17)32135.
    PubMed     Text format     Abstract available


    June 2017
  68. ARTRU F, Louvet A, Ruiz I, Levesque E, et al
    Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3.
    J Hepatol. 2017 Jun 20. pii: S0168-8278(17)32079.
    PubMed     Text format     Abstract available


    May 2017
  69. NADIM MK, DiNorcia J, Ji L, Groshen S, et al
    Inequity In Organ Allocation For Patients Awaiting Liver Transplantation: Rationale for Uncapping the Model for End-Stage Liver Disease.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32003.
    PubMed     Text format     Abstract available


  70. WENDON, J, Cordoba J, Dhawan A, Larsen FS, et al
    EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.
    J Hepatol. 2017;66:1047-1081.
    PubMed     Text format     Abstract available


    April 2017
  71. COLMENERO J, Sancho-Bru P
    Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: one step at a time.
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30215.
    PubMed     Text format    


  72. HIRSCHFIELD GM, Beuers U, Corpechot C, Invernizzi P, et al
    EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.
    J Hepatol. 2017 Apr 17. pii: S0168-8278(17)30186.
    PubMed     Text format     Abstract available


  73. SCHWARZINGER M, Baillot S, Yazdanpanah PY, Rehm PJ, et al
    Contribution of Alcohol Use Disorders on the Burden of Chronic Hepatitis C in France, 2008-2013: A Nationwide Retrospective Cohort Study.
    J Hepatol. 2017 Apr 7. pii: S0168-8278(17)30202.
    PubMed     Text format     Abstract available


    March 2017
  74. QURINO L, Massimo R, Jan L
    Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?
    J Hepatol. 2017 Mar 24. pii: S0168-8278(17)30180.
    PubMed     Text format    


  75. BHAT M, Ghali P, Bilodeau M
    Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?"
    J Hepatol. 2017 Mar 24. pii: S0168-8278(17)30183.
    PubMed     Text format    


  76. BELLI LS, Duvoux C, Berg T, Strazzabosco M, et al
    ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
    J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140.
    PubMed     Text format     Abstract available


  77. DETRY O, Vandermeulen M, Delbouille MH, Somja J, et al
    Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    J Hepatol. 2017 Mar 8. pii: S0168-8278(17)30131.
    PubMed     Text format     Abstract available


  78. BESTE LA, Green PK, Berry K, Kogut MJ, et al
    Effectiveness of hepatitis c antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
    J Hepatol. 2017 Mar 3. pii: S0168-8278(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  79. SAPISOCHIN G, Barry A, Doherty M, Fischer S, et al
    Stereotactic body radiotherapy versus TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
    J Hepatol. 2017 Feb 28. pii: S0168-8278(17)30119.
    PubMed     Text format     Abstract available


    November 2016
  80. NOTARPAOLO A, Layese R, Magistri P, Gambato M, et al
    Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    J Hepatol. 2016 Nov 26. pii: S0168-8278(16)30688.
    PubMed     Text format     Abstract available


  81. MALLET V, Hamed K, Schwarzinger M
    Prognosis of Patients with Chronic Hepatitis B in France (2008-2013): A Nationwide, Observational and Hospital-based Study.
    J Hepatol. 2016 Nov 5. pii: S0168-8278(16)30642.
    PubMed     Text format     Abstract available


    October 2016
  82. BHAT M, Ghali P, Dupont B, Hilzenrat R, et al
    Proposal of a Novel MELD Exception Point System for Hepatocellular Carcinoma based on Tumor Characteristics and Dynamics.
    J Hepatol. 2016 Oct 14. pii: S0168-8278(16)30571.
    PubMed     Text format     Abstract available


  83. VAN DER MEER AJ, Berenguer M
    Reversion of disease manifestations after HCV eradication.
    J Hepatol. 2016;65.
    PubMed     Text format     Abstract available


  84. MORADPOUR D, Grakoui A, Manns MP
    Future landscape of hepatitis C research - Basic, translational and clinical perspectives.
    J Hepatol. 2016;65.
    PubMed     Text format     Abstract available


    September 2016
  85. SHIN WJ, Song JG, Jun IG, Moon YJ, et al
    Effect of ventriculo-arterial coupling on transplant outcomes in cirrhotics: Analysis of pressure-volume curve relations.
    J Hepatol. 2016 Sep 26. pii: S0168-8278(16)30536.
    PubMed     Text format     Abstract available


    April 2016
  86. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available


    January 2016
  87. SCHLEGEL A, Kron P, De Oliveira ML, Clavien PA, et al
    Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?
    J Hepatol. 2016;64:239-41.
    PubMed     Text format    


    September 2015
  88. COILLY A, Samuel D
    Pros and Cons: Usage of organs from donors infected with hepatitis C virus - revision in the direct acting antiviral era.
    J Hepatol. 2015 Sep 12. pii: S0168-8278(15)00617.
    PubMed     Text format     Abstract available


    August 2015
  89. GRANCINI V, Trombetta M, Lunati ME, Zimbalatti D, et al
    Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease.
    J Hepatol. 2015 Aug 19. pii: S0168-8278(15)00553.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: